Success Story: NIW Victory! Ethiopian Research Fellow Approved Without a Single RFE Thanks to Our Assistance

Client’s Testimonial:

“I am deeply grateful to Green North for their extraordinary professionalism and meticulous attention to detail in handling my case. From the very beginning, their expertise and guidance gave me confidence throughout the complex EB-2 NIW (National Interest Waiver) process. On February 26, 2025, I was thrilled to receive my EB-2 NIW approval as a Research Fellow in the field of Biomedical Science.

Green North’s team combined deep knowledge with genuine care, ensuring that every aspect of my application was carefully prepared and strongly presented. Their dedication made an extremely exhaustive I-140 process smooth and successful. I strongly recommend Green North to anyone seeking immigration support; they truly go above and beyond.”

On February 26^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Biomedical Science (Approval Notice).

General Field: Biomedical Science

Position at the Time of Case Filing: Research Fellow

Country of Origin: Ethiopia

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: February 26^th, 2025

Processing Time: 9 months, 25 days

Case Summary:

We are pleased to share the success story of an EB-2 NIW (National Interest Waiver) approval granted to a biomedical science researcher whose work focuses on identifying new drug targets to develop novel small molecule immunomodulatory drugs (IMiDs) aimed at improving cancer treatments. At the time of filing, the client was engaged in impactful research that bridges advanced molecular discovery with translational medicine, with the goal of addressing significant unmet needs in oncology.

Research Focus and Contributions:
The petition highlighted the client’s dedication to pioneering therapeutic strategies for cancer by designing next-generation IMiDs that offer enhanced efficacy with reduced side effects. Their work encompasses:

Investigating the molecular mechanisms underlying cancer progression to identify novel druggable targets
Designing and testing small molecule IMiDs to improve therapeutic outcomes for various malignancies
Integrating preclinical research with translational approaches to accelerate drug development pipelines

Research Impact and Scientific Contributions:
To underscore the significance of the client’s contributions, we emphasized key accomplishments, including:

Publications: 6 peer-reviewed journal articles (1 first-authored) and 2 first-authored abstracts in reputable scientific venues
Citations: 184 citations on Google Scholar, reflecting the recognition of their work within the biomedical research community
Peer Review Service: At least 6 reviews for respected journals, demonstrating active engagement in maintaining the quality of research in their field

Support from Experts in the Field:
The petition was supported by 4 strong letters of recommendation from distinguished researchers, both independent and within collaborative networks. These letters affirmed the client’s role as a forward-thinking scientist whose work could transform cancer treatment paradigms.

“His prowess in advanced genetic engineering, as well as his peer review and editorial contributions to esteemed journals, positions him as a leader in the field, which is valuable to the United States.”

Well Positioned to Advance the Proposed Endeavor:
We demonstrated that the client’s Ph.D. training in frontier biosciences, combined with a strong track record of impactful publications and targeted therapeutic innovations, positions them uniquely to lead advancements in cancer pharmacology. Their prior successes in identifying novel molecular targets and developing therapeutic candidates form a solid foundation for further contributions to the U.S. biomedical research ecosystem.

NIW Approval and Outlook:
Approved in February 2025, this NIW petition recognizes the client’s proven expertise and the national importance of their cancer drug discovery work. NAILG is proud to have guided this case to success and looks forward to the client’s continued impact in developing life-saving cancer therapies.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.